Skip to content
Andelyn Biosciences
-
Andelyn Biosciences to manufacture AAV9-GM2 gene therapy for GM2 gangliosidoses
GM2 gangliosidoses are a group of rare inherited disorders that cause the progressive loss of nerve cells in the brain and spinal cord.